Perguntas e Respostas da Mayo Clinic: Apoiar medicamentos para perda de peso com nutrição adequada e personalizada

Tara Schmidt, nutricionista registrada na Mayo Clinic em Rochester, Minnesota, fornece informações sobre a importância de se discutir nutrição no contexto de medicamentos para a perda de peso.

New Clinical Advances in Gastroenterology Presented at the American College of Gastroenterology’s 86th Annual Scientific Meeting

Featured science includes increased incidence of pancreatic cancer among young women, quality of life improvements in IBD, colorectal cancer risk from weight loss surgery and medications, and more

Semaglutide reduces excess body fat in people with obesity

In adults with obesity or overweight, weekly treatment with the glucagon-like peptide 1 (GLP1) receptor agonist semaglutide leads to reduced excess body fat and increased lean body mass, according to an industry-sponsored study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.